Action Point Financial Planning’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-10
Closed -$328 – 1368
2026
Q2
$328 Buy
+10
New +$315 ﹤0.01% 2675

Other funds holding HRMY

Action Point Financial Planning's HRMY Position: Q3 2026 in Review

Action Point Financial Planning sold out of Harmony Biosciences (HRMY) in Q3 2026, closing a stake of 10 shares — an estimated $328 sold.

Action Point Financial Planning first reported a position in HRMY in Q2 2026 and held it in 1 quarter. The position peaked at $328 in Q2 2026. 358 funds tracked by Wall St. Rank hold HRMY as of Q3 2026.

  • Action Point Financial Planning reported no remaining Harmony Biosciences position as of Q3 2026 after selling out during the quarter.
  • Action Point Financial Planning sold 10 Harmony Biosciences shares in Q3 2026, an estimated $328.
  • Action Point Financial Planning first reported a position in Harmony Biosciences in Q2 2026 and held it in 1 quarter.
  • Action Point Financial Planning's Harmony Biosciences position peaked at $328 in Q2 2026.
  • 358 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2026.

Based on Action Point Financial Planning's 13F filing for Q3 2026, filed 13 Nov 2026.